Changes in levels of neuromarkers and cognitive functioning of patients with treatment-resistant schizophrenia
Abstract
This paper focuses on cognitive functioning in patients with schizophrenia and factors that influence it, including clinical and demographic characteristics and levels of blood biomarkers (neuronspecific enolase and S100B protein). Results of the present study suggest heterogeneity and selectivity of cognitive impairment. Connections between genetic predisposition to schizophrenia and decreased speed of processing, age of onset and the degree of working memory deficits, clinical status features and the speed of skill development, planning, accuracy and impulsivity were established. It was found that the impairment of planning and problem-solving behavior was isolated from other domains. Altered neuronal membrane permeability may contribute to the pathogenesis of memory disorders.
About the Author
M. . Dorofeykova
St. Petersburg Bekhterev Psychoneurological Research Institute
Russian Federation
Russian Federation
References
1. Дроздова К.А., Рупчев Г.Е., Семенова Н.Д. Нарушение вербальной беглости у больных шизофренией. - Социальная и клиническая психиатрия. - 2015. - №4. - С. 9-19.
2. Мосолов С.Н., Потапов А.В., Шафаренко А.А., Костюкова А.Б., Забелина И.Н. Валидизация стандартизированных клиникофункциональных критериев ремиссии при шизофрении. - Соц. И клин. Психиатрия.- 2011. - №3. - С. 36-42.
3. Шмуклер А.Б., Семенкова Е.А. Возрастные особенности нейрокогнитивного дефицита у больных шизофренией и расстройствами шизофренического спектра на начальных этапах заболевания. - Социальная и клиническая психиатрия. - 2013. - №23. - С. 19-23.
4. Янушко М.Г., Иванов М.В., Сорокина А.В. Когнитивные нарушения при эндогенных психозах: современные представления в свете дименсионального подхода. - Социальная и клиническая психиатрия. - 2014. - № 1. - С. 90-95.
5. Asevedo E. et al. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia. - J Psychiatr Res. - 2013. - №47. - Р. 1376-82. doi: 10.1016/j.jpsychires.2013.05.032
6. Bergh S., Hjorthoj C., Sorensen H.J., Fagerlund B., et al. Predictors and longitudinal course of cognitive functioning in schizophrenia spectrum disorders, 10 years after baseline: The OPUS.. - Schizophr. Res. - 2016. doi: http://dx.doi.org/10.1016/j. schres.2016.03.025
7. Fioravanti M., Bianchi V., Cinti M.E. Cognitive deficits in schizophrenia: an updated metanalysis of the scientific evidence. - BMC Psychiatry. - 2012. - №12. - Р. 64. doi: 10.1186/1471-244x-12-64
8. Goldberg T., Green M.F. Neurocognitive functioning in patients with schizophrenia. In: Davis K.L., Charney D., Coyle J.T., Nemeroff C., eds. - Neuropsychopharmacology: The Fifth Generation of Progress. - Philadelphia: Lippincott, Williams, & Wilkins. - 2002. - Р.657-669.
9. Green M.F., Kern, R.S., Heaton, R.K., 2004. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. - Schizophr. Res. - 2004. - №72. - Р 41 51. doi: 10.1016/j.schres.2004.09.009
10. Green M.F., Horan W.P., Sugar C.A. Has the generalized deficit become the generalized criticism? - Schizophr. Bull. - 2013. - 39. - Р. 257262. doi:10.1093/schbul/sbs146
11. Hartmann-Riemer M.N., Hager O.M. et al. The association of neurocognitive impairment with diminished expression and apathy in schizophrenia. - Schizophrenia res. - 2015. - №169. - Р.427-432. doi:http://dx.doi.org/10.1016/j. schres.2015.10.032
12. Heizmann C.W., Fritz G., Schäfer B.W. S100 proteins: structure, functions and pathology. - Front. Biosci. - 2002. - №7. - Р.1356-1368. doi:10.2741/ heizmann
13. Kopald B.E., Mirra K.M., Egan M.F., Weinberger D.R., Goldberg T.E. Magnitude of impact of executive functioning and IQ on episodic memory in schizophrenia. - Biol. Psychiatry. - 2012. - №71. - Р 545-551. doi:10.1016/j.biopsych.2011.11.021
14. Kuperberg G., Heckers S. Schizophrenia and cognitive function. - Curr. Opin. Neurobiol. -2000. - №10. - Р.205-210. doi:10.1016/S0959-4388(00)00068-4
15. Leeson V.C., Robbins T.W., Franklin C., Harrison M., Harrison I., Ron M.A., Barnes T.R.E., Joyce E.M. Dissociation of long-term verbal memory and fronto-executive impairment in first-episode psychosis. - Psychol. Med. - 2009. - №11. - Р. 1-10. doi: 10.1017/s0033291709005935
16. Lesh T.A., Niendam T.A., Minzenberg M.J., Carter C.S. Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning. - Neuropsychopharmacology. - 2011. - №36(1). - Р. 316-338. doi: 10.1038/npp.2010.156
17. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. - Schizophr. Res. - 2004. - №72. - Р 29-39. doi: 10.1016/j.schres.2004.09.007
18. Prouteau A., Verdoux H., Briand C. et al. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. - Schizophr Res. 2005. - №77. - Р.343-353. doi: 10.1016/j. schres.2005.03.001.
19. Ranganath C., Minzenberg M.J., Ragland J.D. The cognitive neuroscience of memory function and dysfunction in schizophrenia. - Biological Psychiatry. - 2008. - №64. - Р. 18-25. doi: 10.1016/j.bio-psych.2008.04.011
20. Reichenberg A., Harvey P.D., Bowie C.R., et al. Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders. - Schizophrenia Bulletin. - 2009. - № 35. - Р. 1022-1029. doi:10.1093/schbul/sbn044
21. Schuepbach D., Keshavan M.S., Kmiec J.A., Sweeney J.A. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. - Schizophr Res. - 2002. - №53. - Р.249-261. doi: 10.1016/ s0920-9964(01)00195-5
22. Silverstein S.M., Osborn L.M., Palumbo D.R. Rey- Osterrieth Complex Figure Test performance in acute, chronic, and remitted schizophrenia patients. - J Clin Psychol. - 1998. - №54. - Р. 985-994.
23. Torrey E.F. Surviving Schizophrenia: A Manual for Families. Patients, and Providers. - 5th ed. New York: HarperCollins. - 2006.
Review
For citations:
Dorofeykova M. Changes in levels of neuromarkers and cognitive functioning of patients with treatment-resistant schizophrenia. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2017;(1):37-44. (In Russ.)
Views:
549
Email this article 